Small Interfering RNA-Mediated Reduction in Heterogeneous Nuclear Ribonucleoparticule A1/A2 Proteins Induces Apoptosis in Human Cancer Cells but not in Normal Mortal Cell Lines

Cancer Research

Volumn 63, Issue 22, 2003, Pages 7679-7688

  Patry, Caroline ^a   Bouchard, Louise ^a   Labrecque, Pascale ^a   Gendron, Daniel ^a   Lemieux, Bruno ^a   Toutant, Johanne ^a   Lapointe, Elvy ^a   Wellinger, Raymund ^a   Chabot, Benoit ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; PROTEIN P53; RNA; STAUROSPORINE;

APOPTOSIS; ARTICLE; BRAIN TUMOR; BREAST CANCER; CANCER CELL; COLON CANCER; CONTROLLED STUDY; DISEASE MARKER; EPITHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; UTERINE CERVIX CANCER;

AMINO ACID SEQUENCE; APOPTOSIS; CELL LINE, TUMOR; EPITHELIAL CELLS; FIBROBLASTS; HELA CELLS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; NEOPLASMS; RNA, SMALL INTERFERING;

EID: 0345275873     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Chakhparonian, M., and Wellinger, R. J. Telomere maintenance and DNA replication: how closely are these two connected? Trends Genet., 19: 439-446, 2003.
2. McElligott, R., and Wellinger, R. J. The terminal DNA structure of mammalian chromosomes. EMBO J., 16: 3705-3714, 1997.
3. Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., and de Lange, T. Mammalian telomeres end in a large duplex loop. Cell, 97: 503-514, 1999.
4. van Steensel, B., and de Lange, T. Control of telomere length by the human telomeric protein TRF1. Nature (Lond.), 385: 740-743, 1997.
5. van Steensel, B., Smogorzewska, A., and de Lange, T. TRF2 protects human telomeres from end-to-end fusions. Cell, 92: 401-413, 1998.
6. n. Mol. Cell. Biol., 13: 4301-4310, 1993.
7. LaBranche, H., Dupuis, S., Ben-David, Y., Bani, M. R., Wellinger, R. J., and Chabot, B. Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nat. Genet., 19: 199-202, 1998.
8. n. Nucleic Acids Res, 20: 6461-6464, 1992.
9. Baumann, P., Podell, E., and Cech, T. R. Human Pot1 (protection of telomeres) protein: cytolocalization, gene structure, and alternative splicing. Mol. Cell. Biol., 22: 8079-8087, 2002.
10. Baumann, P., and Cech, T. R. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science (Wash. DC), 292: 1171-1175, 2001.
11. Karlseder, J., Smogorzewska, A., and de Lange, T. Senescence induced by altered telomere state, not telomere loss. Science (Wash. DC), 295: 2446-2449, 2002.
12. Stewart, S. A., Ben-Porath, I., Carey, V. J., O'Connor, B. F., Hahn, W. C., and Weinberg, R. A. Erosion of the telomeric single-strand overhang at replicative senescence. Nat. Genet., 33: 492-496, 2003.
13. Masutomi, K., Yu, E. Y., Khurts, S., Ben-Porath, I., Currier, J. L., Metz, G. B., Brooks, M. W., Kaneko, S., Murakami, S., DeCaprio, J. A., Weinberg, R. A., Stewart, S. A., and Hahn, W. C. Telomerase maintains telomere structure in normal human cells. Cell, 114: 241-253, 2003.
14. de Lange, T., and Jacks, T. For better or worse? Telomerase inhibition and cancer. Cell, 98: 273-275, 1999.
15. Harley, C. B., Kim, N. W., Prowse, K. R., Weinrich, S. L., Hirsch, K. S., West, M. D., Bacchetti, S., Hirte, H. W., Counter, C. M., Greider, C. W., et al. Telomerase, cell immortality, and cancer. Cold Spring Harb. Symp. Quant. Biol., 59: 307-315, 1994.
16. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Wash. DC), 266: 2011-2015, 1994.
17. Reddel, R. R., Bryan, T. M., Colgin, L. M., Perrem, K. T., and Yeager, T. R. Alternative lengthening of telomeres in human cells. Radiat. Res., 155: 194-200, 2001.
18. Reddel, R. R., Bryan, T. M., and Murnane, J. P. Immortalized cells with no detectable telomerase activity. A review. Biochemistry (Mosc.), 62: 1254-1262, 1997.
19. Hahn, W. C., Stewart, S. A., Brooks, M. W., York, S. G., Eaton, E., Kurachi, A., Beijersbergen, R. L., Knoll, J. H., Meyerson, M., and Weinberg, R. A. Inhibition of telomerase limits the growth of human cancer cells. Nat. Med., 5: 1164-1170, 1999.
20. Herbert, B., Pitts, A. E., Baker, S. I., Hamilton, S. E., Wright, W. E., Shay, J. W., and Corey, D. R. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc. Natl. Acad. Sci. USA, 96: 14276-14281, 1999.
21. Feng, J., Funk, W. D., Wang, S. S., Weinrich, S. L., Avilion, A. A., Chiu, C. P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. The RNA component of human telomerase. Science (Wash. DC), 269: 1236-1241, 1995.
22. Pruzan, R., Pongracz, K., Gietzen, K., Wallweber, G., and Gryaznov, S. Allosteric inhibitors of telomerase: oligonucleotide N3′→P5′ phosphoramidates. Nucleic Acids Res., 30: 559-568, 2002.
23. Gryaznov, S., Pongracz, K., Matray, T., Schultz, R., Pruzan, R., Aimi, J., Chin, A., Harley, C., Shea-Herbert, B., Shay, J., Oshima, Y., Asai, A., and Yamashita, Y. Telomerase inhibitors-oligonucleotide phosphoramidates as potential therapeutic agents. Nucleosides Nucleotides Nucleic Acids, 20: 401-410, 2001.
24. Lichtsteiner, S. P., Lebkowski, J. S., and Vasserot, A. P. Telomerase. A target for anticancer therapy. Ann. N. Y. Acad. Sci., 886: 1-11, 1999.
25. Pascolo, E., Wenz, C., Lingner, J., Hauel, N., Priepke, H., Kauffmann, I., Garin-Chesa, P., Rettig, W. J., Damm, K., and Schnapp, A. Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate. J. Biol. Chem., 277: 15566-15572, 2002.
26. Damm, K., Hemmann, U., Garin-Chesa, P., Hauel, N., Kauffmann, I., Priepke, H., Niestroj, C., Daiber, C., Enenkel, B., Guilliard, B., Lauritsch, I., Muller, E., Pascolo, E., Sauter, G., Pantic, M., Martens, U. M., Wenz, C., Lingner, J., Kraut, N., Rettig, W. J., and Schnapp, A. A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J., 20: 6958-6968, 2001.
27. de Lange, T. Protection of mammalian telomeres. Oncogene, 21: 532-540, 2002.
28. Blackburn, E. H. Telomere states and cell fates. Nature (Lond.), 408: 53-56, 2000.
29. Dreyfuss, G., Matunis, M. J., Pinol-Roma, S., and Burd, C. G. hnRNP proteins and the biogenesis of mRNA. Annu. Rev. Biochem., 62: 289-321, 1993.
30. Dallaire, F., Dupuis, S., Fiset, S., and Chabot, B. Heterogeneous nuclear ribonucleoprotein A1 and UP1 protect mammalian telomeric repeats and modulate telomere replication in vitro. J. Biol. Chem., 275: 14509-14516, 2000.
31. Fiset, S., and Chabot, B. hnRNP A1 may interact simultaneously with telomeric DNA and the human telomerase RNA in vitro. Nucleic Acids. Res., 29: 2268-2275, 2001.
32. Biamonti, G., Bassi, M. T., Cartegni, L., Mechta, F., Buvoli, M., Cobianchi, F., and Riva, S. Human hnRNP protein A1 gene expression. Structural and functional characterization of the promoter. J. Mol. Biol., 230: 77-89, 1993.
33. Zhang, L., Zhou, W., Velculescu, V. E., Kern, S. E., Hruban, R. H., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Gene expression profiles in normal and cancer cells. Science (Wash. DC), 276: 1268-1272, 1997.
34. Iervolino, A., Santilli, G., Trotta, R., Guerzoni, C., Cesi, V., Bergamaschi, A., Gambacorti-Passerini, C., Calabretta, B., and Perrotti, D. hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis. Mol. Cell. Biol., 22: 2255-2266, 2002.
35. Zhou, J., Mulshine, J. L., Unsworth, E. J., Scott, F. M., Avis, I. M., Vos, M. D., and Treston, A. M. Purification and characterization of a protein that permits early detection of lung cancer. Identification of heterogeneous nuclear ribonucleoprotein-A2/B1 as the antigen for monoclonal antibody 703D4. J. Biol. Chem., 271: 10760-10766, 1996.
36. Satoh, H., Kamma, H., Ishikawa, H., Horiguchi, H., Fujiwara, M., Yamashita, Y. T., Ohtsuka, M., and Sekizawa, K. Expression of hnRNP A2/B1 proteins in human cancer cell lines. Int. J. Oncol., 16: 763-767, 2000.
37. Sueoka, E., Goto, Y., Sueoka, N., Kai, Y., Kozu, T., and Fujiki, H. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers. Cancer Res., 59: 1404-1407, 1999.
38. Snead, D., Perunovic, B., Cullen, N., Needham, M., Dhillon, D., Satoh, H., and Kamma, H. hnRNP B1 expression in benign and malignant lung disease. J. Pathol., 200: 88-94, 2003.
39. Yan-Sanders, Y., Hammons, G. J., and Lyn-Cook, B. D. Increased expression of heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP) in pancreatic tissue from smokers and pancreatic tumor cells. Cancer Lett., 183: 215-220. 2002.
40. Yaginuma, Y., and Westphal, H. Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines. Cancer Res., 52: 4196-4199, 1992.
41. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (Lond.), 411: 494-498, 2001.
42. Cimino-Reale, G., Pascale, E., Battiloro, E., Starace, G., Verna, R., and D'Ambrosio, E. The length of telomeric G-rich strand 3′-overhang measured by oligonucleotide ligation assay. Nucleic Acids Res., 29: E35, 2001.
43. Rothmann, T., Hengstermann, A., Whitaker, N. J., Scheffner, M., and zur Hausen, H. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J. Virol., 72: 9470-9478, 1998.
44. Vaziri, H., Squire, J. A., Pandita, T. K., Bradley, G., Kuba, R. M., Zhang, H., Gulyas, S., Hill, R. P., Nolan, G. P., and Benchimol, S. Analysis of genomic integrity and p53-dependent G1 checkpoint in telomerase-induced extended-life-span human fibroblasts. Mol. Cell. Biol., 19: 2373-2379, 1999.
45. Vaziri, H., and Benchimol, S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol., 8: 279-282, 1998.
46. Hubbard, K., Dhanaraj, S. N., Sethi, K. A., Rhodes, J., Wilusz, J., Small, M. B., and Ozer, H. L. Alteration of DNA and RNA binding activity of human telomere binding proteins occurs during cellular senescence. Exp. Cell Res., 218: 241-247, 1995.
47. Karlseder, J., Broccoli, D., Dai, Y., Hardy, S., and de Lange, T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science (Wash. DC). 283: 1321-1325, 1999.
48. Yang, J., Chang, E., Cherry, A. M., Bangs, C. D., Oei, Y., Bodnar, A., Bronslein, A., Chiu, C. P., and Herron, G. S. Human endothelial cell life extension by telomerase expression. J. Biol. Chem., 274: 26141-26148, 1999.
49. Sharma, G. G., Gupta, A., Wang, H., Scherthan, H., Dhar, S., Gandhi, V., Iliakis, G., Shay, J. W., Young, C. S., and Pandita, T. K. hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene, 22: 131-146, 2003.
50. Zhu, J., Wang, H., Bishop, J. M., and Blackburn, E. H. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc. Natl. Acad. Sci. USA, 96: 3723-3728, 1999.
51. Li, G. Z., Eller, M. S., Firoozabadi, R., and Gilchrest, B. A. Evidence that exposure of the telomere 3′ overhang sequence induces senescence. Proc. Natl. Acad. Sci. USA, 100: 527-531, 2003.
52. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S., and Dixit, V. M. Yama/CPP32 β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81: 801-809, 1995.
53. Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond.), 376: 37-43, 1995.